Drug-therapy combo cuts breast cancer recurrence risk by 25%, Eli Lilly announces
Drug-therapy combo cuts breast cancer recurrence risk by 25%, Eli Lilly announces

Eli Lilly and Company on Sunday announced positive results on the fight against breast cancer.
via HTML CODE BLASTER NEWShttps://foxnews.com/health/drug-therapy-breast-cancer-lilly